BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21984555)

  • 1. Are the high mortality rates in dialysis patients mainly due to cardiovascular causes?
    Krediet RT; Boeschoten EW; Dekker FW
    Nephrol Dial Transplant; 2012 Feb; 27(2):481-3. PubMed ID: 21984555
    [No Abstract]   [Full Text] [Related]  

  • 2. Quotidian hemodialysis and inflammation associated with chronic kidney disease.
    Hamlett L; Haragsim L
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e35-42. PubMed ID: 17603973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular problems on hemodialysis: current deficits and potential improvement.
    Ritz E; Bommer J
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S71-8. PubMed ID: 19996009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and noncardiovascular mortality among men and women starting dialysis.
    Carrero JJ; de Jager DJ; Verduijn M; Ravani P; De Meester J; Heaf JG; Finne P; Hoitsma AJ; Pascual J; Jarraya F; Reisaeter AV; Collart F; Dekker FW; Jager KJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1722-30. PubMed ID: 21734088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis: Hypokalaemia and cardiac risk in peritoneal dialysis patients.
    Kwan BC; Szeto CC
    Nat Rev Nephrol; 2012 Sep; 8(9):501-3. PubMed ID: 22801950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albuminuria and cardiovascular risk.
    Bogojevic Z; Bakris GL
    Heart Fail Clin; 2006 Jan; 2(1):53-9. PubMed ID: 17386876
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE inhibitors and survival of hemodialysis patients.
    Efrati S; Zaidenstein R; Dishy V; Beberashvili I; Sharist M; Averbukh Z; Golik A; Weissgarten J
    Am J Kidney Dis; 2002 Nov; 40(5):1023-9. PubMed ID: 12407648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality on maintenance haemodialysis.
    Locatelli F; Del Vecchio L; Manzoni C
    Contrib Nephrol; 1998; 124():166-89; discussion 190-201. PubMed ID: 9761980
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular factors influencing survival in dialysis patients.
    Alpert MA
    Adv Perit Dial; 1996; 12():110-9. PubMed ID: 8865884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis.
    Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1151-5. PubMed ID: 15607622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
    Foley RN; Murray AM; Li S; Herzog CA; McBean AM; Eggers PW; Collins AJ
    J Am Soc Nephrol; 2005 Feb; 16(2):489-95. PubMed ID: 15590763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand.
    Scott DR; Wong JK; Spicer TS; Dent H; Mensah FK; McDonald S; Levy MT
    Transplantation; 2010 Dec; 90(11):1165-71. PubMed ID: 20861806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality rate of patients with end stage renal disease on regular hemodialysis: a single center study.
    Elsharif ME
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):594-6. PubMed ID: 21566330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment.
    La Manna G; Pizza F; Persici E; Baraldi O; Comai G; Cappuccilli ML; Centofanti F; Carretta E; Plazzi G; Colì L; Montagna P; Stefoni S
    Nephrol Dial Transplant; 2011 Jun; 26(6):1976-83. PubMed ID: 21056943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease: the new silent killer.
    Kopyt NP
    J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380
    [No Abstract]   [Full Text] [Related]  

  • 18. Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysis.
    Hocher B; Kalk P; Godes M; Liefeldt L; Ziebig R; Stasch JP; Quaschning T; Pfab T
    Kidney Blood Press Res; 2008; 31(5):360-6. PubMed ID: 19023219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.
    Collins AJ; Foley RN; Gilbertson DT; Chen SC
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S5-11. PubMed ID: 19996006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess cardiovascular mortality in chronic dialysis patients.
    Abbott KC
    Am J Kidney Dis; 2002 Dec; 40(6):1349-50. PubMed ID: 12460060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.